卖什么
AI plus rapid-experiment platform (Orchard) to discover gene-editing targets and design plant traits for crops.
商业模式拆解
买家：谁掌握预算？
未核实R&D and trait-discovery heads at seed, crop-science and plant-breeding companies (partnership with BASF announced); inferred.
触发点：什么让他们现在购买？
Breeding for yield can erode nutrition and flavour; partners want novel, non-canonical targets and faster hypothesis testing than conventional discovery.
工作流：什么输入变成什么输出？
Foundational multimodal modelling, agentic prioritisation, rapid in vitro/transient testing, then trait validation in commercial plant systems.
经济账：省了什么，怎么收费？
Partnership model in three depths: computational discovery, complex edit design, end-to-end trait creation; customer owns downstream trait IP for prediction-only programmes.
渠道：怎么接触到客户？
Partnership/enquiry-led ("Talk to us about a crop, trait or biological challenge").
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| 2026-01-07 | — | €8M | — | news.google.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-12.